---
title: "SIHUAN PHARM repurchased 15 million shares at a total price of 21.76 million yuan"
description: "SIHUAN PHARM announced that on October 17, it repurchased a total of 15 million shares from the market at an average price of 1.4505 yuan per share, with a total purchase price of approximately 21.76 "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/261767839.md"
published_at: "2025-10-19T11:04:02.000Z"
---

# SIHUAN PHARM repurchased 15 million shares at a total price of 21.76 million yuan

> SIHUAN PHARM announced that on October 17, it repurchased a total of 15 million shares from the market at an average price of 1.4505 yuan per share, with a total purchase price of approximately 21.76 million yuan

SIHUAN PHARM (00460.HK) announced that on October 17, it repurchased a total of 15 million shares from the market at an average price of HKD 1.4505 per share, with a total purchase price of approximately HKD 21.76 million

### Related Stocks

- [00460.HK - SIHUAN PHARM](https://longbridge.com/en/quote/00460.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| 领土问题首上谈判桌 俄乌博弈进入 “深水区” | 在日内瓦举行的俄美乌三方谈判中，领土问题首次被纳入讨论议程。谈判于 2 月 17 日至 18 日进行，俄方称谈判 “务实高效”，乌方表示讨论深入且具有实质意义，美方则称各方同意继续谈判。尽管各方均表示取得进展，但关于下一轮谈判的细节尚未公布 | [Link](https://longbridge.com/en/news/276289464.md) |
| Newamsterdam Pharma｜8-K：2025 财年营收 22.5 百万美元 |  | [Link](https://longbridge.com/en/news/276224188.md) |
| 塞拉尼斯｜8-K：2025 财年 Q4 营收 22.04 亿美元不及预期 |  | [Link](https://longbridge.com/en/news/276174089.md) |
| 罗杰斯｜8-K：2025 财年 Q4 营收 2.02 亿美元超过预期 |  | [Link](https://longbridge.com/en/news/276168131.md) |
| 美股异动速递：Knorex 大涨 175.31%，Namib Minerals、Interactive Strength 涨幅超 27%，Beneficient 跌 25% 引关注 | 美股市场概况当前市场呈现出明显的分化趋势，科技股和小盘股的表现尤为突出。Knorex 的暴涨引发了市场的广泛关注，成为短线资金追逐的焦点。同时，医药和能源板块也有不俗表现，NovaBay 制药和 TMD Energy 的涨幅均超过 20%。 | [Link](https://longbridge.com/en/news/276364796.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.